Premium
Lecithin treatment of cognitively impaired Parkinson's patients
Author(s) -
TWEEDY JAMES R.,
GARCIA CARLOS A.
Publication year - 1982
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/j.1365-2362.1982.tb00943.x
Subject(s) - placebo , parkinson's disease , lecithin , medicine , cognition , phosphatidylcholine , disease , gastroenterology , psychology , psychiatry , chemistry , pathology , biochemistry , phospholipid , alternative medicine , membrane
. To test the effects of lecithin on cognitive deficits associated with Parkinson's disease, sixteen elderly and mentally‐impaired outpatients with Parkinson's disease participated in a 9‐week double‐blind placebo‐controlled study. Each patient took a daily dose of approximately 32 g of a commercial lecithin preparation containing 25% phosphatidylcholine, or an equivalent amount of powdered skim milk placebo. Marked clinical improvement was not observed, but some indications of a positive treatment effect were obtained on memory, cognition, and motility tests.